Carregando...
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score
AIM: TNF inhibitor drugs are a treatment option for rheumatoid arthritis, but response is not universal. Response is typically measured using the composite 4-component (4C) disease activity score 28 (DAS28) which contains more subjective measures. This study used a validated 2-component (2C) DAS28 s...
Na minha lista:
| Publicado no: | Pharmacogenomics |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649675/ https://ncbi.nlm.nih.gov/pubmed/33124499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|